FGK Clinical Research GmbH Acquires Clinicology Ltd., Expanding Territorial Footprint in Europe

Press Release

[Munich, 14/02/2024] — FGK Clinical Research GmbH, a European-based full-service provider of clinical research services, is thrilled to announce the successful acquisition of Clinicology Ltd., a UK based Contract Research Organization (CRO). This strategic move marks a significant milestone for both companies, opening new possibilities and strengthening their positions in the European Clinical Research landscape.

Having collaborated for many years already, FGK and Clinicology have cultivated a relationship grounded in mutual respect and a shared vision for operational conduct of clinical studies in Europe. This acquisition marks the evolution of their thriving partnership, unleashing potential and expanding horizons for growth in the dynamic realm of clinical trials.

The acquisition enables FGK to broaden its geographical footprint, leveraging Clinicology's established presence in the UK market. This expanded reach will facilitate quicker access to diverse patient populations and investigator sites in the UK, promoting faster enrollment and completion of clinical studies. Furthermore, a seasoned team based in the UK will superbly complement and enhance the management and operational capabilities of FGK throughout Europe. The combined strengths of FGK and Clinicology will result in a comprehensive service offering, covering the entire spectrum of clinical trial services.
Building on years of collaboration, the integration of FGK and Clinicology will be characterized by a seamless blending of expertise, processes, and technologies.

Martin Krauss, Managing Director of FGK Clinical Research GmbH, expressed enthusiasm about the enhanced partnership, stating, “We are thrilled about the game-changing opportunities this strategic acquisition brings to FGK and Clinicology. Leveraging the synergy of our strengths, we are on track to create unique opportunities for our clients for clinical trials in Europe and beyond.”

Mark Thomas, Managing Director of Clinicology Ltd., commented on the combination of both companies, stating, "The synergies between FGK and Clinicology have been a driving force in multiple successful projects. This acquisition strengthens our collective capabilities."

About FGK Clinical Research GmbH: FGK is a leading full-service clinical research organization (CRO) headquartered in Germany (Munich), providing support for biotechnology, pharmaceutical and medical device companies for clinical studies all over Europe. FGK has more than 230 in-house employees in Germany, Poland, Czech Republic, and Hungary. With acquiring Clinicology, FGK gains highly qualified staff located directly in the UK. With a commitment to quality, efficiency, and customer orientation, FGK offers a range of services, next to clinical trial management (FGK Clinical Research GmbH), affiliates provide European sponsor representative services (FGK Representative Service), and global pharmacovigilance support (FGK Pharmacovigilance).

About Clinicology Ltd.: Clinicology, a long-term partner of FGK Clinical Research GmbH, is a specialized Contract Research Organization (CRO) with offices in Guildford, UK, dedicated to providing high-quality clinical trial services. The acquisition enhances Clinicology's capabilities, positioning the company as a key player in the European clinical trials landscape and enables it to provide a full-service. Clinicology will continue its operations as “Clinicology – an FGK company”.


Martin Krauss, Managing Director of FGK Clinical Research GmbH

Martin Krauss, Managing Director of FGK Clinical Research GmbH